Stem cells for Long COVID: a safety and effectiveness study
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a doctor-confirmed diagnosis of Long COVID based on the WHO definition.
- Your main symptoms (like fatigue, brain fog, or trouble breathing) need to be serious enough to track.
- You must not have active cancer or any active infection.
- Your liver and kidney function must be normal (no more than twice the upper limit).
- If you can become pregnant, you’ll need a negative pregnancy test and agree to use effective non-hormonal birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from donated umbilical cord blood, called REGENECYTE, to see if it helps people with long COVID feel better. It is for adults who still have symptoms after COVID-19 and have tested negative for the virus recently.
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
This trial tests whether a gentle, non-invasive brain stimulation device can help relieve long COVID symptoms. It involves wearing special gloves and socks that deliver mild electrical pulses to improve how you feel.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.
This Phase 2 study tests whether donated-from-your-own-fat stem cells can improve outcomes for people who are high risk for getting COVID-19, but who have never had COVID-19 and test negative right now. It may help your immune system and reduce complications if you become infected during the study.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.